The 2023 Screening Framework Guidance for Providers and Users of Synthetic Nucleic Acids states that advances in the field motivated the United States Government to review and revise the 2010 Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA, and cites the 2010 guidance at 75 FR 62820.
One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.
What it connects
Screening Framework Guidance for Providers and Users of Synthetic Nucleic Acids → supersedes version → Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA
Where it appears
No collection page holds this claim. It is listed with its records in the explorer.